version="1.0" encoding="UTF-8"? version="1.0" encoding="UTF-8"? Sub-navigation Navigation links - Current: Sub-navigation - [ Finprove ](/en/research-and-education/scientific-research/cancer-research/finprove-targeted-anticancer-therapy) - [ Finprove ](/en/research-and-education/scientific-research/cancer-research/finprove-targeted-anticancer-therapy) # FINPROVE - targeted anticancer therapy study The Finprove study investigating the potential for targeted drug therapy in patients with advanced cancer who no longer have other treatment options. Our Comprehensive Cancer Center coordinates the study which is open at all university hospitals in Finland. ## Targeted anticancer therapy Based on changes in the cancer genome, the number of targeted anticancer drugs has increased significantly. There are many anticancer drugs in clinical use that are based on the characteristics of the cancer genome. However, the approved indications for use of these drugs restrict their use in every type of cancer. This study provides the opportunity to use approved medications outside of current indications. ### For professionals --- - The study continues until the end of 2026. - You can assess your patient’s eligibility for the study at [ClinicalTrial.gov](https://clinicaltrials.gov/study/NCT05159245). - Your patient will be referred to a research center in their area (HUS/KYS/TAYS/TYKS/OYS). - The required genetic analysis will be performed according to the hospital’s standard practices. ### For patient --- Talk to the physician treating you about the research treatment. The physician has the best understanding of the stage of the disease and the treatment options available, as well as your potential eligibility for the study. Research participation always requires a referral from your physician. ### For collaborators --- Research is conducted in collaboration with several companies. The medicines and analyses offered by companies enable research work to be conducted, increase the effectiveness of research, and bring new opportunities also to our collaboration partners. We would love to provide you with more information. Please get in touch with the FINPROVE [contact persons.](mailto:katriina.jalkanen@hus.fi;%20tanja.juslin@hus.fi;%20mika.mustonen@hus.fi) ### Molecular Tumor Board (MTB) --- The Finprove study involves the national MTB, or Molecular Tumor Board, which provides treatment recommendations for individual cancer treatment. The Molecular Tumor Board includes a broad group of experts who work together to study the potential for treating molecular changes in a patient’s cancer with targeted cancer medicines. ## European collaboration The study is part of European EU projects that leverage the results and expertise of similar studies in order to achieve results faster. The EU collaboration provides a lot of new training and increased awareness of personalized cancer treatment for officials and patients. [ PRIME-ROSE provides optimization and support for cancer therapy in the EU. Learn more about PRIME-ROSE (opens in new window, links to another website) ](https://www.matrix-fkb.no/en/prime-rose/home)  [ PCM4EU is an EU project that supports the coping and quality of life of cancer patients. Read more about the E3 project (opens in new window, links to another website) ](https://www.matrix-fkb.no/en/pcm4eu/home)  ## Publications --- Here is a list of publications on the topic. - *Jalkanen K et al.* [*A national precision cancer medicine implementation initiative for Finland. Acta Oncol. 2024* ](https://medicaljournalssweden.se/actaoncologica/article/view/32661/46281) - Podcasts on personalized cancer treatment: [PCM4EU podcasts on YouTube (in English)](https://www.youtube.com/@PCM4EU/podcasts) ## Other FINPROVE centers - [ Tampere University Hospital (opens in new window, links to another website) ](https://www.pirha.fi/fi/palvelut/sairaalat-tays/syopa) - [ Wellbeing services county of North Savo (opens in new window, links to another website) ](https://pshyvinvointialue.fi/syopatautien-ja-sadehoidon-palvelut) - [ Turku University Hospital (opens in new window, links to another website) ](https://www.tyks.fi/tietoa-tyksista/tyksin-organisaatio/huippuosaamisyksikot/tyks-syopakeskus) - [ Oulu University Hospital (opens in new window, links to another website) ](https://oys.fi/syopakeskus/) ## Further information on this topic ### [ Comprehensive Cancer Center ](/en/about-us/departments/comprehensive-cancer-center) We are responsible for radiation therapy as well as for the drug therapy for cancer and treatment of hematological diseases in patients over the age of 16…  Updated: 17.06.2025 Print this page